Connecting extracellular metabolomic measurements to intracellular flux states in yeast.
Mo ML, Palsson BO, Herrgård MJ. · 2009
Read Connecting extracellular metabolomic measurements to intracellular flux states in yeast. by Mo ML, Palsson BO, Herrgård MJ. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2679711.txt.
Introduction
Mo, Palsson, and Herrgård showed in 2009 that what yeast spills into its surroundings can reveal the hidden traffic inside its cells. Chemists can measure the chemicals a cell excretes far more easily than the flows among its internal reactions. The team asked whether a genome-scale map of yeast chemistry could turn those outer readings into inner knowledge.
They rebuilt the map, called iMM904, with 904 genes and 1,412 reactions, and checked it against nearly 2,900 gene-deletion growth tests from the literature. Then they fed in measured spill patterns from yeast whose nitrogen handling had been disturbed, in genes or in food. The model's sampled flow patterns matched published inner measurements. The changed flows also pointed back to the right neighborhoods of the network, the ones actually disturbed. Outer chemistry, handled this way, becomes a window on the cell's inner state.
Catalog record
| CREATOR | Mo ML, Palsson BO, Herrgård MJ. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Connecting extracellular metabolomic measurements to intracellular flux states in yeast By Monica L Mo, Bernhard Ø Palsson, Markus J Herrgård Published in: BMC Systems Biology DOI: 10.1186/1752-0509-3-37 ABSTRACT Abstract Background Metabolomics has emerged as a powerful tool in the quantitative identification of physiological and disease-induced biological states. Extracellular metabolome or metabolic profiling data, in particular, can provide an insightful view of intracellular physiological states in a noninvasive manner. Results We used an updated genome-scale metabolic network model of Saccharomyces cerevisiae, iMM904, to investigate how changes in the extracellular metabolome can be used to study systemic changes in intracellular metabolic states. The iMM904 metabolic network was reconstructed based on an existing genome-scale network, iND750, and includes 904 genes and 1,412 reactions. The network model was first validated by comparing 2,888 in silico single-gene deletion strain growth phenotype predictions to published experimental data. Extracellular metabolome data measured in response to environmental and genetic perturbations of ammonium assimilation pathways was then integrated with the iMM904 network in the form of relative overflow secretion constraints and a flux sampling approach was used to characterize candidate flux distributions allowed by these constraints. Predicted intracellular flux changes were consistent with published measurements on intracellular metabolite levels and fluxes. Patterns of predicted intracellular flux changes could also be used to correctly identify the regions of the metabolic network that were perturbed. Conclusion Our results indicate that integrating quantitative extracellular metabolomic profiles in a constraint-based framework enables inferring changes in intracellular metabolic flux states. Similar methods could potentially be applied towards analyzing biofluid metabolome variations related to human physiological and disease states. BACKGROUND "Omics" technologies are rapidly generating high amounts of data at varying levels of biological detail. In addition, there is a rapidly growing literature and accompanying databases that compile this information. This has provided the basis for the assembly of genome-scale metabolic networks for various microbial and eukaryotic organisms [1-11]. These network reconstructions serve as manually curated knowledge bases of biological information as well as mathematical representations of biochemical components and interactions specific to each organism. A genome-scale network reconstruction is a structured collection of genes, proteins, biochemical reactions, and metabolites determined to exist and operate within a particular organism. This network can be converted into a predictive model that enables in silico simulations of allowable network states based on governing physico-chemical and genetic constraints [12,13]. A wide range of constraint-based methods have been developed and applied in order to analyze network metabolic capabilities under different environmental and genetic conditions [13]. These methods have been extensively used to study genome-scale metabolic networks and have successfully predicted, for example, optimal metabolic states, gene deletion lethality, and adaptive evolutionary endpoints [14-16]. Most of these applications utilize optimization-based methods such as flux balance analysis (FBA) to explore the metabolic flux space. However, the behavior of genome-scale metabolic networks can also be studied using unbiased approaches such as uniform random sampling of steady-state flux distributions [17]. Instead of identifying a single optimal flux distribution based on a given optimization criterion (e.g. biomass production), these methods allow statistical analysis of a large range of possible alternative flux solutions determined by constraints imposed on the network. Sampling methods have been previously used to study global organization of E. coli metabolism [18] as well as to identify candidate disease states in the cardiomyocyte mitochondria [19]. Network reconstructions provide a structured framework to systematically integrate and analyze disparate datasets including transcriptomic, proteomic, metabolomic, and fluxomic data. Metabolomic data is one of the more relevant data types for this type of analysis as network reconstructions define the biochemical links between metabolites, and recent advancements in analytical technologies have allowed increasingly comprehensive intracellular and extracellular metabolite level measurements [20,21]. The metabolome is the set of metabolites present under a given physiological condition at a particular time and is the culminating phenotype resulting from various "upstream" control mechanisms of metabolic processes. Of particular interest to this present study are the quantitative profiles of metabolites that are secreted into the extracellular environment by cells under different conditions. Recent advances in profiling the extracellular metabolome (EM) have allowed obtaining insightful biological information on cellular metabolism without disrupting the cell itself. This information can be obtained through various analytical detection, identification, and quantization techniques for a variety of systems ranging from unicellular model organisms to human biofluids [20-23]. Metabolite secretion by a cell reflects its internal metabolic state, and its composition varies in response to genetic or experimental perturbations due to changes in intracellular pathway activities involved in the production and utilization of extracellular metabolites [21]. Variations in metabolic fluxes can be reflected in EM changes which can, in turn, provide insight into the intracellular pathway activities related to metabolite secretion. The extracellular metabolomic approach has already shown promise in a variety of applications, including capturing detailed metabolite biomarker variations related to disease and drug-induced states and characterizing gene functions in yeast [24-27]. However, interpreting changes in the extracellular metabolome can be challenging due to the indirect relationship between the proximal cause of the change (e.g. a mutation) and metabolite secretion. Since metabolic networks describe mechanistic, biochemical links between metabolites, integration of such data can allow a systematic approach to identifying altered pathways linked to observed quantitative changes in secretion profiles. Measured secretion rates of major byproduct metabolites can be applied as additional exchange flux constraints that define observed metabolic behavior. For example, a recent study integrating small-scale EM data with a genome-scale yeast model correctly predicted oxygen consumption and ethanol production capacities in mutant strains with respiratory deficiencies [28]. The respiratory deficient mutant study used high accuracy measurements for a small number of major byproduct secretion rates together with an optimization-based method that are well suited for such data. Here, we expand the application range of the model-based method used in [28] to extracellular metabolome profiles, which represent a temporal snapshot of the relative abundance for a larger number of secreted metabolites. Our approach is complementary to statistical (i.e. "top-down") approaches to metabolome analysis [29] and can potentially be used in applications such as biofluid-based diagnostics or large-scale characterization of mutants strains using metabolite profiles. In this study, we implemented a constraint-based sampling approach on an updated genome-scale network of yeast metabolism to systematically determine how EM level variations are linked to global changes in intracellular metabolic flux states. By using a sampling-based network approach and statistical methods (Figure 1), EM changes were linked to systemic intracellular flux perturbations in an unbiased manner without relying on defining single optimal flux distributions as was used in the previously mentioned study [28]. The inferred perturbations in intracellular reaction fluxes were further analyzed using reporter metabolite and subsystem (i.e., metabolic pathway) approaches [30] in order to identify dominant metabolic features that are collectively perturbed (Figure 2). The sampling-based approach also has the additional benefit of being less sensitive to inaccuracies in metabolite secretion profiles than optimization-based methods and thus can more readily be used in settings such as biofluid metabolome analysis. [Figure: Schematic illustrating the integration of exometabolomic (EM) data with the constraint-based framework. (A) Cells are subjected to genetic and/or environmental perturbations to secrete metabolite patterns unique to that condition. (B) EM is detected, identified, and quantified. (C) EM data is